• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

枸橼酸盐透析治疗低钠血症的可行性:病例系列研究。

Feasibility of Citrate Dialysis in Hyponatremia: A Case Series.

机构信息

ICU Department, Brugmann University Hospital, Brussels, Belgium,

ICU Department, Brugmann University Hospital, Brussels, Belgium.

出版信息

Blood Purif. 2021;50(2):174-179. doi: 10.1159/000509024. Epub 2020 Jul 8.

DOI:10.1159/000509024
PMID:32640446
Abstract

BACKGROUND

Correcting hyponatremia too quickly can lead to osmotic demyelination syndrome. During citrate dialysis, a significant sodium load is brought to the prefilter. We reviewed the impact of this sodium load on the evolution of sodium levels in patients undergoing continuous renal replacement therapy with citrate anticoagulation.

MATERIALS AND METHODS

The medical records of 5 patients with hyponatremia who received dialysis with citrate anticoagulation, over a 10-year period, were reviewed. The sodium of the dialysate and of the reinjection fluid was adapted according to the serum sodium level recommended by the guidelines of the time. Data from the first 24 h after initiation of dialysis was evaluated.

RESULTS

The difference in serum sodium levels between day 1 and day 2 was statistically significant, with a rise of 7.8 ± 3.7 mmol/L.

DISCUSSION

The mean serum sodium increase in our series of patients did not exceed the increase of 10-12 mEq/L/day permitted by the guidelines. The excess sodium was absorbed by the filter.

CONCLUSION

In this small series of patients, with adjustment of the sodium concentration of dialysate and reinjection fluid, the use of citrate was found to be safe.

摘要

背景

过快纠正低钠血症可导致渗透性脱髓鞘综合征。在柠檬酸盐透析过程中,大量钠离子被带到预滤器中。我们回顾了这种钠离子负荷对接受柠檬酸盐抗凝连续肾脏替代治疗的患者钠离子水平演变的影响。

材料和方法

回顾了在过去 10 年中,5 例接受柠檬酸抗凝透析的低钠血症患者的病历。根据当时指南推荐的血清钠水平,调整透析液和再注入液中的钠含量。评估了透析开始后 24 小时内的数据。

结果

第 1 天和第 2 天血清钠水平的差异具有统计学意义,上升了 7.8±3.7mmol/L。

讨论

我们的患者系列中平均血清钠升高未超过指南允许的每天增加 10-12mEq/L。多余的钠被过滤器吸收。

结论

在这组小患者中,通过调整透析液和再注入液中的钠离子浓度,发现使用柠檬酸盐是安全的。

相似文献

1
Feasibility of Citrate Dialysis in Hyponatremia: A Case Series.枸橼酸盐透析治疗低钠血症的可行性:病例系列研究。
Blood Purif. 2021;50(2):174-179. doi: 10.1159/000509024. Epub 2020 Jul 8.
2
Continuous hemodialysis with citrate anticoagulation and standard dialysate for managing acute kidney injury in patients with moderate to severe hyponatremia-A retrospective study.枸橼酸抗凝持续血液透析联合标准透析液治疗中重度低钠血症合并急性肾损伤患者的回顾性研究。
Acta Anaesthesiol Scand. 2021 Jul;65(6):778-784. doi: 10.1111/aas.13798. Epub 2021 Mar 2.
3
Correcting hyponatremia by fluid sodium modulation in continuous renal replacement therapy with regional citrate anticoagulation.在采用局部枸橼酸盐抗凝的连续性肾脏替代治疗中通过调节液体钠含量来纠正低钠血症。
Semin Dial. 2022 Mar;35(2):198-203. doi: 10.1111/sdi.13054. Epub 2022 Jan 20.
4
Correction of hyponatremia by infusing D5W (5% dextrose in water solution) prefilter in patients receiving continuous renal replacement therapy: A case series.在接受连续性肾脏替代治疗的患者中通过输注预滤的5%葡萄糖水溶液(D5W)纠正低钠血症:病例系列
Hemodial Int. 2020 Apr;24(2):E27-E32. doi: 10.1111/hdi.12819. Epub 2020 Feb 20.
5
High sodium continuous veno-venous hemodialysis with regional citrate anticoagulation and online dialysate generation in patients with acute liver failure and cerebral edema.高钠连续性静脉-静脉血液透析联合局部枸橼酸盐抗凝及在线透析液生成治疗急性肝衰竭合并脑水肿患者
Hemodial Int. 2018 Apr;22(2):184-191. doi: 10.1111/hdi.12572. Epub 2017 May 16.
6
A new system for regional citrate anticoagulation in continuous venovenous hemodialysis (CVVHD).一种用于连续性静脉-静脉血液透析(CVVHD)的局部枸橼酸盐抗凝新系统。
Clin Nephrol. 2003 Feb;59(2):106-14. doi: 10.5414/cnp59106.
7
A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.采用含抗凝剂枸橼酸葡萄糖溶液A及含钙置换液的持续性静脉-静脉血液滤过方案。
Int J Artif Organs. 2014 Jun;37(6):499-502. doi: 10.5301/ijao.5000323. Epub 2014 Apr 15.
8
Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A.局部血液透析抗凝:高渗枸橼酸钠或抗凝枸橼酸盐葡萄糖-A
Am J Kidney Dis. 1996 Apr;27(4):519-24. doi: 10.1016/s0272-6386(96)90162-6.
9
Citrate anticoagulation using ACD solution A during long-term haemodialysis.使用 ACD 溶液 A 进行柠檬酸抗凝,适用于长期血液透析。
Nephrology (Carlton). 2011 May;16(4):396-402. doi: 10.1111/j.1440-1797.2010.01421.x.
10
Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.使用市售溶液在连续性静脉-静脉血液透析滤过中进行局部枸橼酸盐抗凝
Nephrol Dial Transplant. 2004 Jan;19(1):171-8. doi: 10.1093/ndt/gfg488.

引用本文的文献

1
Manual Dilution of Continuous Renal Replacement Therapy Fluids in Anuric Patients with Severe Hyponatremia: A Case Report and Systematic Review.无尿性重度低钠血症患者连续性肾脏替代治疗液体的人工稀释:病例报告及系统评价
Case Rep Nephrol Dial. 2025 Jan 29;15(1):26-32. doi: 10.1159/000543718. eCollection 2025 Jan-Dec.